Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.

TitreSwitching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.
Publication TypeJournal Article
Year of Publication2016
AuthorsRotzinger, A, Locatelli, I, Bugnon, O, A. Mello, F, Parienti, JJ, Cavassini, M, Schneider, MP
JournalHiv Medicine
Volume17
Issue5
Start Page390
Pagination390-396
Date PublishedMay/2016
URLhttp://onlinelibrary.wiley.com/doi/10.1111/hiv.12345/epdf
DOI10.1111/hiv.12345
ISSN1468-1293
ISBN Number1468-1293 (Electronic)
Mots-cléscombination, Drug Therapy, efavirenz, HIV, Medication adherence, Medication Therapy Management, patient beliefs, regimen simplification, Tenofovir
Abstract

OBJECTIVES: Simplification of antiretroviral therapy enhances a patient's adherence but a new formulation could also lead to new adverse events and changes in daily routine. This study compared medication adherence, tolerance and satisfaction among subjects switching from a two-tablet tenofovir/emtricitabine/efavirenz regimen to a one-tablet regimen. METHODS: Clinical and sociodemographic data were collected and three surveys were administered at month 0 (=switch), and then 1 and 4-6 months after the switch: the Beliefs about Medicines Questionnaire, the HIV-symptom index questionnaire, the Short HIV Treatment Satisfaction Questionnaire, the Swiss HIV Cohort Study (SHCS) two-item adherence questionnaire, and a questionnaire on daily combination antiretroviral therapy (cART) management. Medication adherence of a subgroup of subjects was routinely monitored using an electronic device (MEMS(™) ). RESULTS: Eighty-eight subjects gave informed consent to participate in the study. The subjects' back-switch rate was 7% (six of 88). Subjects who did not back-switch preferred the one-tablet regimen (median = 2; IQR = 1.3-2.5; on a -3 to 3 scale), but no change in adherence was found (10 of 46 nonadherent subjects; P = 1.00). The perception of treatment necessity score decreased (P = 0.004), the efavirenz blood level increased (14%; P = 0.04), and association/dissociation of cART with food intake evolved (P = 0.01) after the switch. Subjects listed equivalent numbers of symptoms during the three visits. CONCLUSIONS: The one-tablet regimen was preferred but the number of back-switches was not negligible. The perception of treatment necessity score decreased with the simplification of the regimen from a two-tablet to a one-tablet formulation, which could negatively impact adherence. Switching is a sensitive time in a patient's treatment life and professionals should pay particular attention to patient's perceptions of treatment during such a transition.

Alternate URL

https://www.ncbi.nlm.nih.gov/pubmed/26688004

WOS ID (UT)

000374681900010

Alternate JournalHIV Med.
Citation Key / SERVAL IDserval:BIB_FEACD02131F1
Peer reviewRefereed
PubMed ID26688004

                         

IUMSP | www.iumsp.ch
Institut universitaire de médecine sociale et préventive
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | dess.info@unisante.ch

Go to top